|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kato M and Asaka M: Recent knowledge of
the relationship between Helicobacter pylori and gastric cancer and
recent progress of gastroendoscopic diagnosis and treatment for
gastric cancer. Jpn J Clin Oncol. 40:828–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li L, Ying XJ, Sun TT, Yi K, Tian HL, Sun
R, Tian JH and Yang KH: Overview of methodological quality of
systematic reviews about gastric cancer risk and protective
factors. Asian Pac J Cancer Prev. 13:2069–2079. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Resende C, Thiel A, Machado JC and
Ristimäki A: Gastric cancer: Basic aspects. Helicobacter. 16 Suppl
1:S38–S44. 2011. View Article : Google Scholar
|
|
7
|
Thrumurthy SG, Chaudry MA, Chau I and
Allum W: Does surgery have a role in managing incurable gastric
cancer? Nat Rev Clin Oncol. 12:676–682. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ying SY, Chang DC and Lin SL: The microRNA
(miRNA): Overview of the RNA genes that modulate gene function. Mol
Biotechnol. 38:257–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guan A, Wang H, Li X, Xie H, Wang R, Zhu Y
and Li R: MiR-330-3p inhibits gastric cancer progression through
targeting MSI1. Am J Transl Res. 8:4802–4811. 2016.PubMed/NCBI
|
|
12
|
Wu SG, Huang YJ, Bao B, Wu LM, Dong J, Liu
XH, Li ZH, Wang XY, Wang L, Chen BJ and Chen W: miR-508-5p acts as
an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma.
Neoplasma. 64:40–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu H, Duan P, Zhu H and Rao D: miR-613
inhibits bladder cancer proliferation and migration through
targeting SphK1. Am J Transl Res. 9:1213–1221. 2017.PubMed/NCBI
|
|
14
|
Xu J, Jiang N, Shi H, Zhao S, Yao S and
Shen H: (Corrigendum) miR-28-5p promotes the development and
progression of ovarian cancer through inhibition of N4BP1. Int J
Oncol. 50:22362017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Y, Tang Z, Jiang B, Chen J and Fu Z:
miR-198 functions as a tumor suppressor in breast cancer by
targeting CUB domain-containing protein 1. Oncol Lett.
13:1753–1760. 2017.PubMed/NCBI
|
|
16
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen P, Zhao H, Huang J, Yan X, Zhang Y
and Gao Y: MicroRNA-17-5p promotes gastric cancer proliferation,
migration and invasion by directly targeting early growth response
2. Am J Cancer Res. 6:2010–2020. 2016.PubMed/NCBI
|
|
19
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng G, Wang H, Zhang X, Yang Y, Wang L,
Du L, Li W, Li J, Qu A, Liu Y and Wang C: Identification and
validation of reference genes for qPCR detection of serum microRNAs
in colorectal adenocarcinoma patients. PLoS One. 8:e830252013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xin J, Zhang XK, Xin DY, Li XF, Sun DK, Ma
YY and Tian LQ: FUS1 acts as a tumor-suppressor gene by
upregulating miR-197 in human glioblastoma. Oncol Rep. 34:868–876.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Li F, Saha MN, Abdi J, Qiu L and
Chang H: miR-137 and miR-197 induce apoptosis and suppress
tumorigenicity by targeting MCL-1 in multiple myeloma. Clin Cancer
Res. 21:2399–2411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong L, Qin S, Li Y, Zhao L, Dong S, Wang
Y, Zhang C and Han S: High expression of astrocyte elevated gene-1
is associated with clinical staging, metastasis, and unfavorable
prognosis in gastric carcinoma. Tumour Biol. 36:2169–2178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jian-bo X, Hui W, Yu-long H, Chang-hua Z,
Long-juan Z, Shi-rong C and Wen-hua Z: Astrocyte-elevated gene-1
overexpression is associated with poor prognosis in gastric cancer.
Med Oncol. 28:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Du C, Yi X, Liu W, Han T, Liu Z, Ding Z,
Zheng Z, Piao Y, Yuan J, Han Y, et al: MTDH mediates trastuzumab
resistance in HER2 positive breast cancer by decreasing PTEN
expression through an NFκB-dependent pathway. BMC Cancer.
14:8692014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu C, Kong X, Wang H, Zhang N, Kong X,
Ding X, Li X and Yang Q: MTDH mediates estrogen-independent growth
and tamoxifen resistance by down-regulating PTEN in MCF-7 breast
cancer cells. Cell Physiol Biochem. 33:1557–1567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang TY, Liu SG, Zhao BS, Qi B, Qin XG and
Yao WJ: Implications of microRNA-197 downregulated expression in
esophageal cancer with poor prognosis. Genet Mol Res. 13:5574–5581.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dai W, Wang C, Wang F, Wang Y, Shen M,
Chen K, Cheng P, Zhang Y, Yang J, Zhu R, et al: Anti-miR-197
inhibits migration in HCC cells by targeting KAI 1/CD82. Biochem
Biophys Res Commun. 446:541–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mavridis K, Gueugnon F, Petit-Courty A,
Courty Y, Barascu A, Guyetant S and Scorilas A: The oncomiR miR-197
is a novel prognostic indicator for non-small cell lung cancer
patients. Br J Cancer. 112:1527–1535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shaker O, Maher M, Nassar Y, Morcos G and
Gad Z: Role of microRNAs −29b-2, −155, −197 and −205 as diagnostic
biomarkers in serum of breast cancer females. Gene. 560:77–82.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu J, Liu G, Zhao Z, Jia W and Xia H:
MicroRNA-197 mediates the overgrowth and anti-apoptotic effects by
downregulating insulin-like growth factor-binding protein-3 during
nephroblastoma tumorigenesis. Fetal Pediatr Pathol. 35:287–298.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hamada S, Satoh K, Miura S, Hirota M,
Kanno A, Masamune A, Kikuta K, Kume K, Unno J, Egawa S, et al:
miR-197 induces epithelial-mesenchymal transition in pancreatic
cancer cells by targeting p120 catenin. J Cell Physiol.
228:1255–1263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tian LQ, Liu EQ, Zhu XD, Wang XG, Li J and
Xu GM: MicroRNA-197 inhibits cell proliferation by targeting GAB2
in glioblastoma. Mol Med Rep. 13:4279–4288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun Z, Zhou N, Han Q, Zhao L, Bai C, Chen
Y, Zhou J and Zhao RC: MicroRNA-197 influences 5-fluorouracil
resistance via thymidylate synthase in colorectal cancer. Clin
Transl Oncol. 17:876–883. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang H, Su X, Yang M, Chen T, Hou J, Li N
and Cao X: Reciprocal control of miR-197 and IL-6/STAT3 pathway
reveals miR-197 as potential therapeutic target for hepatocellular
carcinoma. Oncoimmunology. 4:e10314402015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wan L and Kang Y: Pleiotropic roles of
AEG-1/MTDH/LYRIC in breast cancer. Adv Cancer Res. 120:113–134.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gnosa S, Shen YM, Wang CJ, Zhang H,
Stratmann J, Arbman G and Sun XF: Expression of AEG-1 mRNA and
protein in colorectal cancer patients and colon cancer cell lines.
J Transl Med. 10:1092012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Zhang N, Song LB, Liao WT, Jiang LL,
Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS and Li M: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu JQ, Zhou Q, Zhu H, Zheng FY and Chen
ZW: Overexpression of astrocyte elevated gene-1 (AEG-1) in cervical
cancer and its correlation with angiogenesis. Asian Pac J Cancer
Prev. 16:2277–2281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang G, Zhang L, Lin S, Li L, Liu M, Chen
H, Cao M, Liu D, Huang YR and Bo J: AEG-1 is associated with tumor
progression in nonmuscle-invasive bladder cancer. Med Oncol.
31:9862014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche
H, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1)
functions as an oncogene and regulates angiogenesis. Proc Natl Acad
Sci USA. 106:21300–21305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang CF, Xia YH, Zheng QF, Li ZJ, Guo XH,
Zhou HC, Zhang LL, Dong LP, Han Y, Liu ZE, et al: Effect of
silencing AEG-1 with small interfering RNA on the proliferation and
cell cycle of gastric carcinoma SGC-7901 cells. Zhonghua Zhong Liu
Za Zhi. 35:22–27. 2013.(Article In Chinese). PubMed/NCBI
|
|
50
|
Tang Y, Liu X, Su B, Zhang Z, Zeng X, Lei
Y, Shan J, Wu Y, Tang H and Su Q: MicroRNA-22 acts as a metastasis
suppressor by targeting metadherin in gastric cancer. Mol Med Rep.
11:454–460. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shen X, Si Y, Yang Z, Wang Q, Yuan J and
Zhang X: MicroRNA-542-3p suppresses cell growth of gastric cancer
cells via targeting oncogene astrocyte-elevated gene-1. Med Oncol.
32:3612015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li S, Guo X, Ma X, Tang C, Ke Z and Huang
W: Expression of astrocyte elevated gene-1 closely correlates with
the angiogenesis of gastric cancer. Oncol Lett. 7:1447–1454.
2014.PubMed/NCBI
|
